RSS

ALERTS, HOT STOCKS & CHARTS

Last Post: 3:58 PM
Followers: 548
Posts Today: 1
Views Today: 16244
  1. jim50
  2. jim50
  3. FLA
  4. FLA
  5. FLA
  6. jim50

Top 10 Most Recent News Articles

Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 119

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Effective Youth Hockey Skills: Mastering the Basics

Updated Category News Views 35

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Continue Reading
Ares Commercial Real Estate Gears Up for Q3 Earnings

Updated Category News Views 37

Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 4

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 180

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
CASEKOO's Spooky Collectibles: Postcards Meet Cases

Updated Category News Views 65

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Columbus McKinnon Completes Significant Notes Offering for Growth

Updated Category News Views 97

Columbus McKinnon Completes Important Notes Offering Columbus McKinnon Corporation (NASDAQ: CMCO), a prominent designer and manufacturer in the intelligent motion solutions sector, has successfully completed a notable offering of senior secured notes. This offering totaled $900 million with a set interest rate of 7.125%, maturing in 2033, aimed at supporting the company's...

Continue Reading
Navigating TransMedics Gr's Upcoming Earnings Like a Pro

Updated Category News Views 195

Rollin' into Earnings: What to Expect from TMDX Every now and then, a company catches wind in its sails, and TransMedics Gr (NASDAQ:TMDX)—well, it’s been riding a decent wave lately. With earnings about to drop on February 24, 2026, folks are buzzing, holding their breath, and looking for that golden info nugget to drop. Analysts are pinning their hopes on an earnings...

Continue Reading
Rigel Pharmaceuticals Set to Showcase Innovations at J.P. Morgan

Updated Category News Views 108

Rigel Pharmaceuticals Gears Up for J.P. Morgan Healthcare Conference Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a prominent name in biotechnology focused on hematologic disorders and cancer treatments, is poised to make a significant impact at the upcoming J.P. Morgan Healthcare Conference. The event is set to bring together industry leaders and innovators, making it an...

Continue Reading
Big Lots Introduces Festive Shopping Event Amid Holiday Cheers

Updated Category News Views 293

Exciting Updates from Big Lots This Holiday Season Big Lots is gearing up for the holiday season with some thrilling news for all shoppers. The launch of their new Holiday Shop is set to delight customers, combined with an unforgettable one-day shopping event called ‘Falloweenmas’ which offers great savings and unique decorations for this festive time of year....

Continue Reading
Amcor Welcomes Stephen Scherger as New CFO Amid Changes

Updated Category News Views 273

Amcor Announces New Leadership with Stephen R. Scherger Amcor, a global frontrunner in packaging solutions, has appointed Stephen R. Scherger as its new Executive Vice President and Chief Financial Officer, effective November 10, 2025. This decision comes as the current CFO, Michael Casamento, steps down after dedicating a decade to the company. He will continue in an...

Continue Reading